Cannell & Co. Acquires 167,275 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Cannell & Co. increased its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2,478.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 174,025 shares of the company's stock after purchasing an additional 167,275 shares during the quarter. Cannell & Co. owned approximately 0.10% of Option Care Health worth $5,863,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. lifted its position in shares of Option Care Health by 11.8% in the 3rd quarter. Vanguard Group Inc. now owns 19,319,352 shares of the company's stock worth $624,981,000 after purchasing an additional 2,037,162 shares during the period. Third Point LLC lifted its holdings in Option Care Health by 55.7% in the third quarter. Third Point LLC now owns 5,450,659 shares of the company's stock valued at $176,329,000 after buying an additional 1,950,659 shares during the period. FMR LLC boosted its position in Option Care Health by 10.8% during the third quarter. FMR LLC now owns 3,717,299 shares of the company's stock valued at $120,255,000 after acquiring an additional 362,828 shares during the last quarter. Wellington Management Group LLP boosted its position in Option Care Health by 15.9% during the third quarter. Wellington Management Group LLP now owns 2,896,392 shares of the company's stock valued at $93,698,000 after acquiring an additional 397,627 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in Option Care Health by 5.1% during the 3rd quarter. Northern Trust Corp now owns 2,477,480 shares of the company's stock worth $80,146,000 after acquiring an additional 120,212 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.


Analyst Ratings Changes

A number of brokerages have recently issued reports on OPCH. Jefferies Financial Group boosted their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "buy" rating in a research note on Monday, March 4th. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 24th.

Check Out Our Latest Stock Report on OPCH

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the company's stock in a transaction on Monday, February 26th. The shares were purchased at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the purchase, the director now owns 269,528 shares of the company's stock, valued at $8,503,608.40. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by company insiders.

Option Care Health Stock Down 0.3 %

Shares of NASDAQ OPCH traded down $0.09 during trading on Thursday, hitting $29.89. 1,373,205 shares of the company traded hands, compared to its average volume of 1,307,490. The firm has a market capitalization of $5.20 billion, a price-to-earnings ratio of 19.58, a P/E/G ratio of 1.45 and a beta of 1.26. The business's fifty day moving average is $31.75 and its 200 day moving average is $31.44. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.39 and a current ratio of 1.77. Option Care Health, Inc. has a fifty-two week low of $24.23 and a fifty-two week high of $35.74.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.22 by $0.04. The firm had revenue of $1.15 billion during the quarter, compared to analysts' expectations of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The company's revenue for the quarter was up 12.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.21 earnings per share. Equities research analysts predict that Option Care Health, Inc. will post 1.19 earnings per share for the current fiscal year.

Option Care Health Company Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Further Reading

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Should you invest $1,000 in Option Care Health right now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

Search Headlines: